Eastman Chemical (EMN) Cash & Equivalents (2009 - 2026)

Eastman Chemical (EMN) has reported Cash & Equivalents for 18 consecutive years, with $691.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 63.36% year-over-year to $691.0 million; the trailing twelve-month figure through Jun 2026 stood at $691.0 million (up 63.36% YoY), and the FY2025 full-year result was $566.0 million, down 32.38% from the prior year.
• Cash & Equivalents climbed to $691.0 million in Q2 2026 per EMN's latest filing, from $665.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $837.0 million in Q4 2024 and bottomed at $410.0 million in Q2 2023.
• Historically, Cash & Equivalents has averaged $534.3 million across 5 years, with a median of $496.0 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Cash & Equivalents sank 35.7% in 2022, then surged 63.36% in 2026.
• Over 5 years, Cash & Equivalents stood at $493.0 million in 2022, then grew by 11.16% to $548.0 million in 2023, then surged by 52.74% to $837.0 million in 2024, then slumped by 32.38% to $566.0 million in 2025, then climbed by 22.08% to $691.0 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $691.0 million, $665.0 million, and $566.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.